Yervoy, also known as ipilimumab, is a medication used to treat certain types of cancer, including melanoma. Insurance coverage for Yervoy can vary depending on several factors, including your location, insurance provider, and specific plan.

According to the Yervoy prescribing information, the cost of treatment can be high due to the medication's complex development and the ongoing clinical trial process that was involved before the medication was approved (Source: [1]). In a study conducted, it was estimated that the cost of Yervoy treatment can range from $93,000 to $139,000 per patient per year [2].

Insurance coverage of Yervoy treatment costs often depends on a patient's insurance plan, including private insurance, Medicaid, and Medicare. Many insurance plans cover the cost of Yervoy, but some may not, or may require additional approval (Source: [3]). Patients can check their insurance coverage by contacting their insurance provider and asking about their coverage for Yervoy.

You can also check the DrugPatentWatch.com website for information on Yervoy patents, pricing, and manufacturer Merck & Co., Inc [4]. Additionally, you can check with your doctor or healthcare provider for guidance on accessing Yervoy treatment through clinical trials or patient assistance programs.

Sources:

[1] https://www.merck.com/product/usa/picircullant/pialphabetical/yervoy/yervoy_ppi.pdf
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4441416/
[3] https://www.insure.com/healthinsurance/melanoma-treatment-costs.html
[4] https://www.druggatentwatch.com/ipilimumab